Acquired inhibitory body hemophilia;Erworbene hemmkorperhamophilie

Anaesthesist

Volumn 49, Issue 1, 2000, Pages 34-42

  Scharrer, I ^a   Grossmann R ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Acquired haemophilia; Diagnosis; Spontaneous factor IX inhibitors; Spontaneous factor VIII inhibitors; Therapy

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7;

ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR DEFICIENCY; DISEASE ASSOCIATION; HEMOPHILIA; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; HEMOPHILIA A; IMMUNOLOGY; PATHOPHYSIOLOGY; REVIEW;

AUTOANTIBODIES; FACTOR IX; FACTOR VII; HEMOPHILIA A; HUMANS;

EID: 0033961091     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050007     Document Type: Article

References (65)

1. 1. Addiego J, Kasper C, Abildgaard C, Hilgartner M, Lusher J, Glader B, Aledort L (1993) Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII. Lancet 342:462-464
2. 2. Algiman M, Dietrich G, Nydegger UE, Boieldieu D, Sultan Y, Kazatchkine MD (1992) Natural antibodies to factor VIII in healthy individuals. Proc Natl Acad Sci USA 89:3795-3799
3. 3. Batlle J, Gomez E, Rendal E Torea J, Loures E, Couselo M, Vila P, Sedano C, Tusell X, Magallon M, Quintana M, Gonzalez-Boullosa R, Lopez-Fernandez MF (1996) Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects. Ann Hematol 72:321-326
4. 4. Biggs R, Austen DE, Denson KW, Rizza CR, Borrett R (1972a) The mode of action of antibodies which destroy factor VIII: I. Antibodies which have second-order concentration graphs. Br J Haematol 23:125-135
5. 5. Biggs R, Austen DE, Denson KW, Borrett R, Rizza CR (1972b) The mode of action of antibodies which destroy factor VIII: II. Antibodies which give complex concentration graphs. Br J Haematol 23:137-155
6. 6. Brackmann HH (1984) Induced immunotolerance in factor VIII inhibitor patients. Prog Clin Biol Res 150:181-185
7. 7. Castro O, Farber LR, Clyne LP (1972) Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus. Ann of Intern Med 77:543-548
8. 8. Cohen AJ, Kessler CM (1996) Acquired inhibitors. Baill Clin Haemat 9:331-354
9. 9. Coller BS, Hultin MB, Hoyer LW, Miller F, Dobbs JV, Dosik MH, Berger ER (1981) Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood 58:619-624
10. 10. Freiburghaus C, Berntorp E, Ekman M, Gunnarsson M, Kjellberg BM, Nilsson IM (1998) Immunoadsorption for removal of inhibitors: update on treatments in Malmo-Lund between 1980 and 1995. Haemophilia 4:16-20
11. 11. Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I and the Association of Hemophilia Centre Directors of Canada (1998) Adetailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Thromb Haemost 79:872-875
12. 12. Green D, Lechner K (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 45:200-203
13. 13. Green D, Rademaker AW, Briet E (1993) A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 70:753-757
14. 14. Großmann R, Geisen U, Schwender S, Keller F (1999) Diagnostik und Therapiesteuerung bei erworbenen Faktoreninhibitoren. J Lab Med 23:70-78
15. 15. Großmann R, Wankmüller H, Schwender S, Kirschner J, Mansouri-Taleghani B, Keller F, Kodisiek K (1996) Diagnose und Therapie eines erworbenen F-VIII-Inhibitors in Kombination mit Lupus-Antikoagulanzien. Dtsch Med Wschr 121:906-910
16. 16. Hay CRM (1998) Acquired haemophilia. Baill Clin Haemat 11:287-303
17. 17. Hay CRM, Lozier JN, Lee CA, Laffan M, Tradati F, Santagostino E, Ciavarella N, Schiavoni M, Fukui H, Yoshioka A, Teitel J, Mannucci PM, Kasper CK (1996) Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia A and inhibitors: the results of an international survey. Thromb Haemost 75:25-29
18. 18. Hay CRM, Negrier C, Ludlam CA (1997) The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.Thromb Haemost 78:1463-1467
19. 19. Hedner U (1996) Dosing and monitoring NovoSeven® treatment. Haemostasis 26:102-108
20. 20. Hedner U, Ingerslev J (1998) Clinical use of recombinant FVIIa (rFVIIa).Transfus Sci 19:163-176
21. 21. Hilgartner M, Aledort L, Andes A, Gill J (1990) Efficacy and safety, of vapor heated antiinhibitor coagulant complex in hemophilia patients. FEIBA Study Group. Transfusion 30:626-630
22. 22. Huhmann I, Lechner K (1996) Spontane Faktor-VIII-Inhibitoren. Hämostaseologie 16:164-170
23. 23. Huth-Kühne A (1999) Persönliche Mitteilung. Kurpfalzklinik gGmbH, Heidelberg.
24. 24. Kasper CK, Aledort LM, Counts RB, Edson JR, Fratantoni J, Green D, Hampton JW, Hilgartner MW, Lazerson J, Levine PH, McMillan PW, Pool JG, Shapiro SS, Shulman NR, van Eys J (1975) A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 34:869-872
25. 25. Kessler CM, Ludlam CA (1993) The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. Semin Hematol 30 (Suppl 1):22-27
26. 26. Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, Gilchrist GS, Gill JC, Glader B, Hoots WK, Kisker CT, Lusher JM, Rosenfield CG, Shapiro AD, Smith H, Taft E (1998) Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (NovoSeven) in haemophiliacs with inhibitors. Thromb Haemost 80:912-918
27. 27. Knöbl P, Derfler K, Korninger L, Kapiotis S, Jäger U, Maier-Dobersberger T, Hörl W, Lechner K, Pabinger I (1995) Elimination of acquired factor VIII antibodies by extracorporal antibody-based IA (Ig-Therasorb®). Thromb Haemost 74:1035-1038
28. 28. Largo R, Sigg P, von Felten A, Straub PW (1974) Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease. Br J Haematol 26:129-140
29. 29. Lavergne JM, Meyer D, Reisner H (1976) Characterization of human antifactor VIII antibodies purified by immune complex formation. Blood 48:931-936
30. 30. Lechner K (1971) Factor IX inhibitors: report of two cases and a study of the biological, chemical and immunological properties of the inhibitors. Thromb Diath Haemorrh 25:447-459
31. 31. Lian ECY, Larcada AF, Chiu AYZ (1989) Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 110, 10:774-778
32. 32. Lottenberg R, Kentro TB, Kitchens CS (1987) Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med 147:1077-1081
33. 33. Lusher JM (1994) Use of prothrombin complex concentrates in the management of bleeding in hemophiliacs with inhibitors -benefits and limitations. Semin Haematol 31:49-52
34. 34. Lusher JM, Shapiro SS, Palacak JE, Rao AV, Levine PH, Blatt PM and the Haemophilia Study Group (1980) Efficacy of prothrombin complex concentrates in hemophiliacs with antibodies to factor VIII:a multicenter therapeutic trial. N Engl J Med 303:421-425
35. 35. Mansouri-Taleghani B, Großmann R, Keller F, Wiebecke D (1998) Therapy of coagulation factor VIII autoantibodies with long-term extracorporeal protein A adsorption and immunosuppression. Transfus Sci 19:39-42
36. 36. Michiels JJ, Bosch LJ, van der Plas PM, Abels J (1978) Factor VIII-inhibitor postpartum. Scand J Coll Haematol 20:97-107
37. 37. Miller K, Neeley JE, Krivit W, Edson JR (1978) Spontaneously acquired factor IX inhibitor in a nonhemophiliac child. J Pediatr 93:232-234
38. 38. Morrison AE, Ludlam CA (1995) Acquired haemophilia and its management. Br J Haematol 89:231-236
39. 39. Morrison AE, Ludlam CA, Kessler C (1993) Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 81:1513-1520
40. 40. Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P and the members of the French FEIBA study group (1997) Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. Thromb Haemost 77:1113-1119
41. 41. Nilsson IM, Berntorp E, Freiburghaus C (1993) Treatment of patients with factor VIII and IX inhibitors. Thromb Haemost 70:56-59
42. 42. Nilsson IM, Berntorp E, Zettervall O (1988) Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII. N Engl J Med 318:947-950
43. 43. Nilsson IM, Berntorp E, Zettervall O, Dahlbäck B (1990) Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients. Blood 75:378-383
44. 44. Özsoylu S, Özer FL (1973) Acquired factor IX deficiency. A report of 2 cases. Acta Haematol 50:305-314
45. 45. Peerlinck K, Rosendaal FR, Vermylen J (1993) Incidence of inhibitor development in a group of young hemophilia A patients treated exclusively with lyophilized cryoprecipitate. Blood 81:3332-3335
46. 46. Rizza CR, Edgcumbe JO, Pitney WR, Child JA (1972) The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII). Thromb Diath Haemorrh 28:120-128
47. 47. Scandella D, Mattingly M, deGraaf S, Fulcher CA (1989) Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization. Blood 74:618-1628
48. 48. Scharrer I (1986) Erworbene Antikörper gegen Gerinnungsfaktoren. Hämostaseologie 6:89-92
49. 49. Scharrer I (1995) Spontan erworbene Hemmkörperhämophilie. Intensiv-und Notfallmedizin 20:90-92
50. 50. Scharrer I (1996) Erworbene Inhibitoren gegen Faktor IX. Hämostaseologie 16:171 -173
51. 51. Schulman S for the rFVIIa-CI Group (1998) Safety, efficacy and lessons from continuous infusion with rFVIIa. Haemophilia 4:564-567
52. 52. Schwaab R, Brackmann HH, Meyer C, Seehafer J, Kirchgesser M, Haack A, Olek K, Tuddenham EG, Oldenburg J (1995) Haemophilia A: mutation type determines risk of inhibitor formation. Thromb Haemost 74:1402-1406
53. 53. Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM (1995) A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 86:797-804
54. 54. Shaffer LG, Phillips MD (1997) Successful treatment of acquired hemophilia with oral immunosuppressive therapy. Ann Intern Med 127:206-209
55. 55. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA (1998) Prospective, randomised trial of two doses of rFVIIa (Novo-Seven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 80:773-778
56. 56. Sherman LA, Goldstein MA, Sise HS (1969) Circulating anticoagulant (antifactor VIII) treated with immunosuppressive drugs. Thromb Diath Haemorrh 21:249-258
57. 57. Slocombe GW, Newland AC, Colvin MP, Colvin BT (1981) The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII. Br J Haematol 47:577-585
58. 58. Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger U (1984) Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 2:765-768
59. 59. Sultan Y, Kazatchkine MD, Nydegger U, Rossi F, Dietrich G, Algiman M (1991) Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors. Am J Med 91:S35-S39
60. 60. Sultan Y, Kazatchkine MD, Algiman M, Dietrich G, Nydegger U (1994) The use of intravenous immunoglobulins in the treatment of factor VIII inhibitors. Semin Haematol 31:65-66
61. 61. Thompson AR, Murphy MEP, Liu ML, Saenko EL, Healey JF, Lollar P, Scandella D (1997) Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation. Blood 90:1902-1910
62. 62. Van Beek EJR, Peters M, ten Cate JW (1993) Factor VIII inhibitor associated with ciprofloxazin. Thromb Haemost 69:403
63. 63. Vermylen J (1998) How do some haemophiliacs develop inhibitors? Haemophilia 4:538-542
64. 64. Vicente V, Alberea L, Gonzales R et al. (1987) Normal pregnancy in a patient with postpartum FVIII inhibitor. Am J Hematol 24:107-109
65. 65. Zeitler H, Unkrig C, Brackmann H, Effenberger C, Hanfland D, Stier S, Ko Y, Vetter H (1997) An immunomodulatory treatment of acquired hemophilia A with longterm IgG IA, immunosuppression, and antigen substitution - a modified Bonn protocol inducing immmune tolerance. Blood [Suppl 1] 90:36A (Abstract)